Medical device startup Envista Holdings Corp. brought in $643.7m in the largest IPO among all biopharma and medtech firms. The firm had been Danaher Corp.'s dental subsidiary; however, following the offering the companies began operating as separate public entities. Envista is organized through two operating segments: specialty products and technologies, and equipment and consumables.
Leading the pack in the biopharma sector was Denmark-based Genmab AS, which raised over half a billion dollars. The...